Gender disparities, causes and predictors of immediate and short-term cardiovascular readmissions following COVID-19-related hospitalisations in the USA.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 11 2023
Historique:
medline: 13 11 2023
pubmed: 11 11 2023
entrez: 10 11 2023
Statut: epublish

Résumé

In this study, we aimed to identify the causes, predictors and gender disparities of 30-day and 90-day cardiovascular readmissions after COVID-19-related hospitalisations using National Readmission Database (NRD) 2020. We used the NRD from 2020 to identify hospitalised adults with a principal diagnosis of COVID-19 infection. We included subjects who were readmitted within 30 days and 90 days after index admission. We excluded subjects with elective and traumatic admissions. We used a multivariate Cox regression model to identify independent predictors of readmission. Our outcomes were inpatient mortality, 30-day and 90-day cardiovascular readmission rates following COVID-19 infection. During the study period, there were 1 024 492 index hospitalisations with a primary diagnosis of COVID-19 infection in the 2020 NRD database, 644 903 (62.9%) were included for 30-day readmission analysis, and 418 122 (40.8%) were included for 90-day readmission analysis. Of patients involved in the 30-day analysis, 7140 (1.1%) patients had a readmission within 30 days; of patients involved in the 90-day analysis, 8379 (2.0%) had a readmission within 90 days due to primarily cardiovascular causes. Cox regression analysis revealed that the female sex (aHR 0.89; 95% CI 0.82 to 0.95; p=0.001) was associated with a lower hazard of 30-day cardiovascular readmissions; however, congestive heart failure (aHR 2.45; 95% CI 2.2 to 2.72; p<0.001), arrhythmias (aHR 2.45; 95% CI 2.2 to 2.72; p<0.001) and valvular disease (aHR 2.45; 95% CI 2.2 to 2.72; p<0.001) had a higher hazard. The most common causes of cardiovascular readmissions were heart failure (34.3%), deep vein thrombosis/pulmonary embolism (22.5%) and atrial fibrillation (9.5%). Our study demonstrates that male gender, heart failure, arrhythmias and valvular disease carry higher hazards of 30-day and 90-day cardiovascular readmissions. Identifying risk factors and common causes of readmission may assist with lowering the burden of cardiovascular disease in patients with COVID-19 infection.

Identifiants

pubmed: 37949624
pii: bmjopen-2023-073959
doi: 10.1136/bmjopen-2023-073959
pmc: PMC10649490
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e073959

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Eur Heart J. 2020 Jun 7;41(22):2070-2079
pubmed: 32391877
JAMA Cardiol. 2020 Nov 01;5(11):1265-1273
pubmed: 32730619
Circulation. 2020 Jun 9;141(23):1903-1914
pubmed: 32297796
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Pers Med. 2022 Jan 04;12(1):
pubmed: 35055360
J Am Coll Cardiol. 2022 May 3;79(17):1717-1756
pubmed: 35307156
J Clin Med. 2022 Apr 15;11(8):
pubmed: 35456309
EClinicalMedicine. 2022 Nov;53:101700
pubmed: 36281441
Eur Respir J. 2020 Jul 30;56(1):
pubmed: 32398297
Microorganisms. 2022 Aug 29;10(9):
pubmed: 36144340
Life Sci. 2020 Jul 15;253:117723
pubmed: 32360126
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Nat Med. 2022 Mar;28(3):583-590
pubmed: 35132265
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
JAMA. 2020 Nov 3;324(17):1723-1724
pubmed: 33031513
Heart. 2022 May 25;108(12):923-931
pubmed: 35273122
CJC Open. 2023 May 4;:
pubmed: 37362314
Nature. 2021 Jun;594(7862):259-264
pubmed: 33887749
Heart Fail Rev. 2023 Jul;28(4):859-864
pubmed: 36572763
Eur Heart J. 2022 Mar 14;43(11):1157-1172
pubmed: 35176758
Cureus. 2021 Dec 14;13(12):e20407
pubmed: 35047250
Eur Radiol. 2023 Jun;33(6):3867-3877
pubmed: 36512043
FASEB J. 2020 Sep;34(9):11347-11354
pubmed: 33078484
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Radiology. 2021 Feb;298(2):E70-E80
pubmed: 33320063

Auteurs

Ufuk Vardar (U)

Department of Medicine, John H Stroger Jr Hospital of Cook County, Chicago, Illinois, USA ufukvardar96@gmail.com.

Hafeez Shaka (H)

Department of Medicine, John H Stroger Jr Hospital of Cook County, Chicago, Illinois, USA.

Dennis Kumi (D)

Department of Medicine, John H Stroger Jr Hospital of Cook County, Chicago, Illinois, USA.

Rohan Gajjar (R)

Department of Medicine, John H Stroger Jr Hospital of Cook County, Chicago, Illinois, USA.

Olva Bess (O)

Department of Medicine, Woodhull Hospital, Brooklyn, New York, USA.

Philip Kanemo (P)

Department of Medicine, Rapides Regional Medical Center, Alexandria, Louisiana, USA.

Abdultawab Shaka (A)

Department of Medicine, Windsor University School of Medicine, Cayon, Saint Kitts and Nevis.

Naveen Baskaran (N)

Department of Medicine, University of Florida, Gainesville, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH